跳至主要内容
临床试验/JPRN-UMIN000007271
JPRN-UMIN000007271招募中未知

Multicenter study on the clinical usefulness of a new method diagnosing earlier development of pancreatic fibrosis, which targets proteolytic TGF-B-activation reaction. - Multicenter study on diagnostic usefulness of TGF-B LAP-D for early stage of chronic pancreatitis.

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2012年2月13日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients with infections, difficult to control, for examples active tuberculosis. 2.Patients with severe drug allergy. 3.Patients with difficulty in the performance of endoscopy. 4.Patients with malignancy. 5.Patients with history of anticancer drug. 6.Patients with possible causes developing hepatic fibrosis without alcohol consumption, such as, viral hepatitis, autoimmune hepatitis,non-alcoholic steatohepatitis, and CBD stones etc. 7.Patients with two times or more of the level of normal alanine transaminase (ALT). 8.Patients with interstitial pneumoniae and lung fibrosis. 9.Patients with severe complications. 10.Patients with pregnancy, lactating, possibility of pregnancy, or will of pregnancy. 11.Patients with severe mental disorder.

研究者

发起方
Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine

相似试验